Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of type 2 diabetes: NICE guidelines.

Literature DB >> 19728510

Management of type 2 diabetes: NICE guidelines.

Latika Sibal¹, Philip D Home.

Abstract

Entities: Disease

Mesh：

Year: 2009 PMID： 19728510 PMCID： PMC4952504 DOI： 10.7861/clinmedicine.9-4-353

Source DB: PubMed Journal: Clin Med (Lond) ISSN： 1470-2118 Impact factor: 2.659

× No keyword cloud information.

10 in total

1. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors: E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal: N Engl J Med Date: 2001-09-20 Impact factor: 91.245

2. Modulation of the renin-angiotensin system and retinopathy.

Authors: N Chaturvedi
Journal: Heart Date: 2000-09 Impact factor: 5.994

3. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.

Authors: A I Adler; I M Stratton; H A Neil; J S Yudkin; D R Matthews; C A Cull; A D Wright; R C Turner; R R Holman
Journal: BMJ Date: 2000-08-12

4. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.

Authors: Deepak L Bhatt; Steven P Marso; Alan T Hirsch; Peter A Ringleb; Werner Hacke; Eric J Topol
Journal: Am J Cardiol Date: 2002-09-15 Impact factor: 2.778

5. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors: Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan
Journal: Kidney Int Date: 2005-06 Impact factor: 10.612

6. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors:
Journal: BMJ Date: 1998-09-12

Review 7. Antihypertensive agents for preventing diabetic kidney disease.

Authors: G F M Strippoli; M Craig; J C Craig
Journal: Cochrane Database Syst Rev Date: 2005-10-19

8. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

Authors: R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal: Arch Ophthalmol Date: 1984-04

9. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.

Authors: Tina Ken Schramm; Gunnar H Gislason; Lars Køber; Søren Rasmussen; Jeppe N Rasmussen; Steen Z Abildstrøm; Morten Lock Hansen; Fredrik Folke; Pernille Buch; Mette Madsen; Allan Vaag; Christian Torp-Pedersen
Journal: Circulation Date: 2008-03-31 Impact factor: 29.690

10. Effect of a multifactorial intervention on mortality in type 2 diabetes.

Authors: Peter Gaede; Henrik Lund-Andersen; Hans-Henrik Parving; Oluf Pedersen
Journal: N Engl J Med Date: 2008-02-07 Impact factor: 91.245

10 in total

14 in total

Review 1. Mobile applications for diabetes self-management: status and potential.

Authors: Omar El-Gayar; Prem Timsina; Nevine Nawar; Wael Eid
Journal: J Diabetes Sci Technol Date: 2013-01-01

2. Estimation of expected life-years saved from successful prevention of end-stage renal disease in elderly patients with diabetes: a nationwide study from Taiwan.

Authors: Deng-Chi Yang; Lukas Jyuhn-Hsiarn Lee; Chih-Cheng Hsu; Yu-Yin Chang; Ming-Cheng Wang; Wei-Hung Lin; Chia-Ming Chang; Jung-Der Wang
Journal: Diabetes Care Date: 2012-08-08 Impact factor: 19.112

Review 3. Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines.

Authors: Taridzo Chomutare; Luis Fernandez-Luque; Eirik Arsand; Gunnar Hartvigsen
Journal: J Med Internet Res Date: 2011-09-22 Impact factor: 5.428

Review 4. Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control.

Authors: Carolina C R Betônico; Silvia M O Titan; Maria Lúcia C Correa-Giannella; Márcia Nery; Márcia Queiroz
Journal: Clinics (Sao Paulo) Date: 2016-01 Impact factor: 2.365

5. Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes.

Authors: Peter P Swoboda; Bara Erhayiem; Rachel Kan; Adam K McDiarmid; Pankaj Garg; Tarique A Musa; Laura E Dobson; Klaus K Witte; Mark T Kearney; Julian H Barth; Ramzi Ajjan; John P Greenwood; Sven Plein
Journal: Cardiovasc Diabetol Date: 2018-03-05 Impact factor: 9.951

6. Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure.

Authors: Peter P Swoboda; Adam K McDiarmid; Bara Erhayiem; David P Ripley; Laura E Dobson; Pankaj Garg; Tarique A Musa; Klaus K Witte; Mark T Kearney; Julian H Barth; Ramzi Ajjan; John P Greenwood; Sven Plein
Journal: J Am Heart Assoc Date: 2017-07-17 Impact factor: 5.501